{"doc_key": "sents_context_AND_True", "dataset": "ace05", "sentences": [["Further", "work", "is", "urgently", "needed", "to", "determine", "the", "impact", "of", "decontamination", "technologies", "on", "respirator", "function", "."], ["The", "APPs", "are", "generated", "as", "a", "systemic", "response", "not", "only", "to", "acute", "inflammatory", "stimuli", "but", "also", "to", "chronic", "inflammation", "."], ["Thus", ",", "we", "can", "utilize", "our", "identified", "APPs", "as", "markers", "to", "predict", "active", "TB", "and", "other", "inflammatory", "diseases", ",", "but", "further", "studies", "and", "including", "active", "TB", "and", "other", "inflammatory", "diseases", "into", "the", "studies", "are", "needed", "to", "confirm", "this", "prediction", "."], ["While", "the", "present", "study", "adds", "to", "the", "existing", "body", "of", "knowledge", "in", "the", "perceived", "risk", "associated", "with", "online", "transactions", "by", "examining", "the", "given", "model", "between", "the", "online", "customers", "considering", "an", "emerging", "economy", ",", "several", "limitations", "are", "present", "that", "remain", "to", "be", "addressed", "and", "creates", "an", "avenue", "for", "future", "research", "."], ["First", ",", "the", "sample", "has", "189", "respondents", "."], ["By", "examining", "complex", "interactions", "of", "SARS-CoV-2", "with", "the", "cells", "present", "within", "the", "OE", ",", "we", "could", "be", "better", "prepared", "for", "that", "type", "of", "virus", "."], ["Future", "studies", "should", "also", "investigate", "how", "age-related", "differences", "affect", "SARS-CoV-2", "actions", "in", "the", "OE", "."], ["Finally", ",", "the", "scenario", "that", "the", "OEORN", "is", "involved", "in", "mediating", "the", "rapid", "response", "of", "the", "immune", "system", "is", "well", "worth", "investigating", "and", "must", "be", "experimentally", "verified", "."], ["Several", "experimental", "drugs", "have", "been", "approved", "by", "FDA", "with", "unknown", "efficacy", "and", "potential", "adverse", "effects", "."], ["The", "exponentially", "spreading", "pandemic", "of", "COVID-19", "deserves", "prime", "public", "health", "attention", "to", "evaluate", "yet", "unexplored", "arenas", "of", "management", "."], ["We", "opine", "that", "one", "of", "these", "treatment", "options", "is", "low", "dose", "radiation", "therapy", "for", "severe", "and", "most", "critical", "cases", "."], ["Other", "murine", "studies", "have", "reported", "that", "CHIKV", "primarily", "infects", "the", "liver", ",", "muscles", ",", "joints", ",", "spleen", "and", "brain", ",", "displaying", "a", "tropism", "characteristic", "of", "CHIKV", "pathogenesis", "in", "human535455", "."], ["Thus", "in", "our", "murine", "model", ",", "quantification", "of", "viremia", ",", "virus", "load", "and", "examining", "histopathologic", "changes", "are", "necessary", "to", "further", "investigate", "the", "antiviral", "efficacy", "of", "CPMO1v", "."], ["Here", ",", "we", "found", "that", "viremia", "was", "significantly", "reduced", "by", "2.8", "log", "in", "mice", "treated", "with", "15", "gg", "CPMO1v", "as", "well", "as", "at", "least", "2", "log", "reduction", "of", "virus", "load", "in", "the", "spleen", ",", "liver", ",", "brain", "and", "limbs", ",", "collectively", "."], ["Approximately", "1.9", "million", "of", "those", "cases", "and", "107,000", "of", "those", "deaths", "are", "within", "the", "USA", ",", "with", "372,000", "cases", "and", "24,000", "deaths", "within", "New", "York", "State", "3", "."], ["Currently", ",", "there", "is", "no", "specific", "anti-viral", "therapy", "or", "vaccine", "available", "for", "COVID-19", "."], ["By", "using", "an", "experimental", "model", "in", "which", "a", "specific", "molecular", "pathway", "is", "activated", ",", "we", "would", "be", "able", "to", "demonstrate", "that", "TLR3", "signaling", "is", "one", "of", "the", "components", "of", "an", "immunological", "reaction", "during", "viral", "infections", "in", "the", "olfactory", "mucosa", "."], ["Other", "signaling", "pathways", "could", "be", "evaluated", "using", "the", "same", "methodology", "."], ["The", "transmission", "of", "SARS-CoV-2", "and", "severity", "of", "COVID-19", "infections", "may", "embody", "a", "clinal", "pattern", "specifically", "related", "to", "HA", "with", "subsequent", "physiological", "advantages", "over", "COVID-19", "being", "possible", "among", "HA", "populations", "."], ["Future", "research", "could", "benefit", "from", "utilizing", "existing", "genetic", "and", "physiological", "data", "pertaining", "to", "HA", "populations", "to", "evaluate", "presented", "theories", "related", "to", "the", "prevalence", "of", "SARS-CoV-2", "and", "severity", "of", "COVID-19", "among", "HA", "populations", "."], ["These", "results", "should", "be", "interpreted", "with", "caution", "in", "advance", "of", "a", "severe", "pandemic", "that", "could", "cause", "prolonged", "disruption", "of", "daily", "life", "and", "widespread", "illness", "in", "a", "community", "."], ["Adherence", "rates", "to", "recommendations", "might", "be", "high", "during", "the", "early", "stages", "of", "a", "pandemic", "but", "results", "may", "not", "be", "as", "predictive", "over", "the", "course", "of", "several", "months", "."], ["We", "have", "more", "confidence", "in", "the", "predictive", "ability", "of", "the", "survey", "in", "areas", "in", "which", "the", "public", "has", "a", "greater", "amount", "of", "personal", "experience", ",", "e.g.", ",", "workplace", "issues", ",", "income", ",", "and", "the", "need", "for", "assistance", "at", "home", "."], ["This", "may", "have", "an", "impact", "on", "the", "outcome", "of", "disease", ",", "in", "respect", "to", "resolution", "or", "severity", "Figure", "2", "."], ["However", ",", "the", "relationship", "between", "infections", "with", "other", "organisms", "and", "M.", "tuberculosis", "have", "not", "been", "well-described", "."], ["In", "this", "article", "we", "aim", "to", "bring", "together", "all", "the", "available", "evidence", "into", "one", "review", "."], ["In", "addition", ",", "we", "observed", "adults", "to", "shed", "HRV-A", "longer", "than", "HRV-C.", "Longer", "shedding", "of", "HRV-A", "among", "adults", "may", "be", "correlated", "to", "more", "severe", "clinical", "presentation", "with", "such", "species", "."], ["Further", "studies", "are", "needed", "to", "understand", "interaction", "of", "host", "response", "and", "viral", "virulence", "."], ["To", "the", "best", "of", "our", "knowledge", ",", "this", "is", "the", "first", "study", "to", "describe", "species-specific", "and", "age-specific", "differences", "in", "the", "patterns", "of", "viral", "shedding", "during", "natural", "HRV", "infection", "."], ["However", ",", "a", "potential", "downside", "of", "baricitinib", "is", "that", "it", "can", "impair", "innate", "immunity", "by", "reducing", "interferons", "response", "which", "is", "deemed", "critical", "to", "control", "viral", "replication", "68", "."], ["In", "a", "case", "report", ",", "IL-6", "inhibitortocilizumab", "possibly", "prevented", "development", "of", "severe", "COVID-19", "complications", "in", "someone", "who", "had", "been", "taking", "it", "for", "scleroderma", "associated", "interstitial", "lung", "disease", "ILD", "70", "."], ["Tocilizumab", "is", "currently", "being", "commonly", "used", "in", "critically", "ill", "patients", "with", "COVID-19", "and", "has", "been", "associated", "with", "good", "outcomes", "71", ",", "72", "."], ["The", "induction", "of", "de", "novo", "immune", "responses", "against", "such", "viruses", "relies", "on", "their", "recognition", "by", "nave", ",", "and", "not", "memory", ",", "T", "cells", "."], ["Since", ",", "the", "pool", "of", "nave", "T", "cells", "decreases", "with", "age", ",", "reaching", "very", "low", "numbers", "in", "the", "elderly", "Briceno", "et", "al.", "2016", ",", "we", "believe", "that", "this", "may", "contribute", "to", "the", "age-dependent", "development", "of", "the", "disease", "and", "to", "the", "greater", "severity", "of", "symptoms", "and", "death", "in", "the", "elderly", ",", "characterizing", "these", "emerging", "infections", "."], ["There", "were", "several", "interesting", "and", "unexpected", "findings", "in", "this", "study", "that", "likely", "resulted", "from", "the", "ability", "of", "this", "methodology", "to", "facilitate", "frequent", "and", "longitudinal", "monitoring", "of", "a", "cohort", "of", "immunosuppressed", "patients", "at", "risk", "for", "acquiring", "RVI", "."], ["First", ",", "we", "detected", "9", "additional", "respiratory", "viruses", "i.e.", "new", "viral", "episodes", "in", "6", "40", "of", "15", "patients", "during", "the", "course", "of", "monitoring", "of", "their", "initial", "RVI", "."], ["In", "the", "cases", "where", "LyssaVax", "is", "cross-neutralizing", ",", "it", "is", "unknown", "whether", "the", "sera", "contain", "individual", "cross-reactive", "antibodies", "or", "whether", "discrete", "populations", "of", "antibodies", "bind", "to", "each", "antigen", "both", "possibilities", "likely", "contribute", "."], ["This", "question", "can", "be", "answered", "only", "by", "isolating", "and", "characterizing", "mAbs", ",", "a", "goal", "of", "future", "studies", "."], ["Knowledge", "of", "where", "physiologically", "relevant", "antibodies", "bind", "on", "non-RABV", "lyssavirus", "Gs", "will", "be", "important", "for", "detailed", "study", "of", "how", "LyssaVax", "elicits", "protective", "antibodies", "against", "multiple", "lyssaviruses", "."], ["Many", "researches", "prove", "that", "economic", "policy", "uncertainty", "Baker", "et", "al.", ",", "2016", "is", "an", "extremely", "important", "factor", "driving", "volatilities", "of", "financial", "markets", "see", "Fang", "et", "al.", ",", "2019", "Wang", "et", "al.", ",", "2019", "Wang", "et", "al.", ",", "2020", "for", "example", "."]], "predicted_ner": [[[13, 13, "PER", 19.8652, 1.0]], [], [[38, 38, "PER", 3.7188, 0.8599], [41, 41, "PER", 8.9239, 0.9937]], [[103, 103, "PER", 6.5619, 0.9946]], [[132, 132, "PER", 30.1001, 1.0]], [[148, 148, "PER", 7.4656, 0.9786]], [], [[180, 180, "ORG", 8.687, 0.9975]], [[209, 209, "ORG", 25.4243, 1.0]], [], [[237, 237, "PER", 4.9876, 0.7343]], [], [[289, 289, "GPE", 3.0294, 0.4322]], [[314, 314, "FAC", 0.2703, 0.5531], [316, 316, "PER", 4.3633, 0.9146]], [[370, 370, "GPE", 23.4649, 1.0], [379, 381, "GPE", 10.9228, 1.0]], [], [[412, 412, "PER", 6.6542, 0.9816]], [], [[477, 477, "LOC", 12.9225, 1.0]], [[493, 493, "LOC", 7.4802, 0.9922], [510, 510, "LOC", 9.65, 0.9996]], [[538, 538, "PER", 7.1095, 0.9777]], [], [[568, 568, "PER", 4.909, 0.935], [580, 580, "LOC", 14.646, 1.0], [582, 582, "LOC", 9.0799, 0.9998], [584, 584, "PER", 5.1621, 0.9739], [595, 595, "FAC", 5.6136, 0.9959], [606, 606, "GPE", 0.9998, 0.4499]], [], [], [[648, 648, "PER", 4.491, 0.6579]], [[664, 664, "PER", 2.1595, 0.7351], [666, 666, "PER", 13.8319, 1.0], [678, 678, "PER", 13.8211, 1.0]], [[699, 699, "PER", 5.3134, 0.9947]], [[709, 709, "PER", 5.6007, 0.9077]], [[743, 743, "GPE", 4.0245, 0.8469]], [[777, 777, "PER", 21.7606, 1.0], [778, 778, "PER", 13.3574, 1.0]], [[801, 801, "PER", 8.3552, 0.9997], [803, 803, "WEA", 3.0122, 0.9515]], [[824, 824, "WEA", 0.8484, 0.4555]], [[858, 859, "ORG", 0.9076, 0.6409], [863, 863, "PER", 3.6114, 0.8521]], [[924, 924, "PER", 11.3026, 1.0]], [[933, 933, "PER", 7.5294, 0.9936], [948, 948, "PER", 13.1335, 1.0], [955, 955, "PER", 18.126, 1.0]], [[972, 972, "LOC", 0.456, 0.5228], [980, 980, "LOC", 1.7827, 0.7486], [986, 986, "ORG", 0.0911, 0.2988]], [[1008, 1008, "ORG", 2.811, 0.9275]], [[1035, 1035, "WEA", 0.0107, 0.4886]], [[1044, 1045, "ORG", 4.7956, 0.9916], [1061, 1061, "ORG", 11.107, 1.0], [1065, 1065, "ORG", 5.4956, 0.9959], [1066, 1066, "ORG", 10.1062, 1.0], [1070, 1071, "ORG", 0.4334, 0.6066], [1071, 1071, "ORG", 8.7048, 0.9998]]], "predicted_relations": [[], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []]}
